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Abstract 
Background: Falls continue to be a problem for older people in long‑term care (LTC) and retirement home (RH) set‑
tings and are associated with significant morbidity and health care use. Fall‑risk increasing drugs (FRIDs) are known to 
increase fall risk and represent modifiable risk factors. There are limited data regarding the use of FRIDs in contempo‑
rary LTC and RH settings, and it has not been well documented to what extent medication regimens are reviewed and 
modified for those who have sustained falls. The objective of this study is to characterize medication related fall risk 
factors in LTC and RH residents and on‑going use of medications known to increase fall risk.
Methods: Retrospective chart review of residents aged >65 who sustained one or more falls living in LTC or RH 
settings.
Results: 105 residents who fell one or more times during 2009–2010 were identified with a mean age of 89 years, a 
mean of nine scheduled medications and seven diagnoses, and 83 % were women. Residents in LTC were ostensibly 
at higher risk for falls relative to those in RH settings as suggested by higher proportion of residents with multiple falls, 
multiple comorbidities, comorbidities that increase fall risk and visual impairment. Post fall injuries were sustained by 
42 % of residents, and residents in RH sustained more injuries relative to LTC residents (47 vs 34 %). Use of FRIDs such 
as benzodiazepines, antipsychotic, antidepressant and various antihypertensive drugs was common in the present 
sample. No medication regimen changes were noted in the 6‑month post fall period.
Conclusions: The present study documented common use FRIDs by LTC and RH residents with multiple falls. These 
potentially modifiable falls risk factors are not being adequately addressed in contemporary practice, demonstrating 
that there is much room for improvement with regards to the safe and appropriate use of medications in LTC and RH 
residents.
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Background
Falls are a pervasive problem among older people, espe-
cially those living in long-term care (LTC) and assisted 
living [also known as retirement home (RH)] settings [1, 
2]. One third of community dwelling older (>65  years) 
adults fall at least once per year, increasing to 50 % among 
those aged ≥80  years and over 60  % for those living in 
LTC settings [3–6]. Furthermore, long-term care dwellers 
have more than twice higher risk for falls, having a mean 
1.7 falls per person-year compared to those living in com-
munity settings who have a mean of 0.65 falls per person-
year [1]. Falls are a leading cause of significant morbidity 
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and mortality in older people, lead to poor overall func-
tioning, represent 85 % of injury-related hospital admis-
sions in this age group and are the most common cause 
for emergency department visits by LTC residents [1, 2, 
7]. Injurious falls may be devastating for those suffering 
outcomes such as hip fractures (falls account for 95 % of 
all hip fractures among older people in Canada), subse-
quent partial or permanent post-fall disability, or perma-
nent institutionalization [2].
Falls in older people are due to multiple intrinsic (e.g., 
cognition, mobility) and/or extrinsic (e.g., environment, 
medications) risk factors, the latter of which are of par-
ticular interest, as medication related fall risk factors are 
well described in the literature [8–12]. Specifically, taking 
≥4 medications is associated with an increased fall risk, 
as are certain medication types (e.g., psychotropic medi-
cations, blood pressure lowering medications) have been 
consistently associated with an increased fall risk [8–10, 
13]. In addition, use of multiple medications in older 
people is commonplace with 2/3 of community dwell-
ing older people taking 5 or more medications, while 
their long term care counterparts consume an average 
of 10 medications daily [14]. As such, it may be argued 
that medications are one of the most important risk fac-
tors for falls given their high rate of use and the potential 
for their modification [8, 9, 15]. Indeed, modifying high 
risk medications can lower fall risk and fall rates in older 
people. For example, in a randomised, controlled trial of 
psychotropic medication withdrawal and home based 
exercise program to prevent falls, Campbell et  al. [16] 
observed a relative hazard for falls of 0.34 (95 % CI 0.16, 
0.74) in the medication withdrawal group. Similarly, van 
der Velde et al. [17] observed a hazard ratio of 0.48 (95 % 
CI 0.23, 0.99) in a group of geriatric outpatients who had 
fall risk increasing drugs (FRIDs) withdrawn versus those 
whose medication regimens remained unchanged. Thus, 
there is support to the notion that modifying high-risk 
medication regimens can decrease fall risk and fall rates 
in older people [18]. In addition, failure to consider medi-
cations as possible causes/contributors to falls and failure 
to translate research evidence into practice can hamper 
any proposed comprehensive fall reduction strategies [9, 
15].
Previous studies demonstrating associations between 
certain medications and their association with fall risk 
have documented baseline levels of psychotropic or car-
diovascular medication use, yet there are relatively few 
contemporary studies that describe current trends of 
FRID use among older residents with a documented fall 
history in Canadian LTC facilities and/or in RH settings 
[19–21]. For example, Neutel et  al. [21] documented 
the use of antidepressant (64 %), benzodiazepine (61 %), 
other sedatives (64 %), cardiovascular medications (58 %) 
and diuretics (59 %) in a sample (n = 125) of LTC resi-
dents who fell. It is logical to focus efforts in a high risk 
population such as older people in LTC settings, but it is 
also important to include people at risk in RH settings, 
as they are higher functioning and are more likely to be 
ambulating independently. As such, it is vital to avoid 
falls that may lead to fractures and functional impair-
ment ultimately resulting in a need for permanent LTC 
placement. Furthermore, given the potential to reduce 
fall risk by modifying high-risk medications, it is impor-
tant to assess whether or not a fall might trigger a proper 
and thorough medication review in these settings, as 
prior studies in other settings have documented contin-
ued use of FRIDs among older people who have fallen or 
sustained a hip fracture, which ostensibly represents a 
missed opportunity to improve the care of these vulner-
able people [22, 23].
Existing data are also limited in that they do not pro-
vide detailed insights at the facility level or within the 
context of everyday practice. Appropriate management 
of residents who sustain a fall requires a diligent post fall 
assessment, including careful review of potentially modi-
fiable risk factors, including medications. It is therefore 
essential to assess contemporary patterns of FRID use as 
well as current patterns of clinical care for residents who 
fall in order to identify opportunities to improve the care 
of older people [1, 11, 24]. There is also a need to under-
stand current practices at the facility level to conceptual-
ize rational solutions to improve any identified problems 
and identify desirable practices that should be continued. 
Previous studies have not documented these important 
issues. The present study sought to characterize medica-
tion related fall risk factors in LTC and RH residents who 
sustained one or more falls and to explore post fall medi-
cation use in these residents over a 1 year time period.
Purpose
The objectives of this study were to (1) describe cur-
rent patterns of FRID use in LTC and RH residents who 
sustained one or more falls during a 1-year time period 
(2009–2010) and (2) to explore current post-fall practices 
as they relate to the on-going use of FRIDs.
Design and methods
Setting, study participants, and information sources
This was a cross-sectional study of residents from a pri-
vate, for-profit, retirement facility in Ontario, Canada 
with a continuum of care ranging from independent liv-
ing to assisted care [referred to as retirement home (RH)] 
and long term care with a census of 311 beds (95 LTC and 
216 RH beds). This facility is one of 13 retirement facili-
ties in this region operated by a senior living organization 
providing services to approximately 3309 older residents 
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in South-western Ontario. Each facility maintains an on-
going registry of incident falls as part of routine clinical 
care protocols. Each fall case report form is completed 
by any nursing home staff who first becomes aware of 
the fall, then the form is immediately sent to the facility 
kinesiologist and charge nurse for post-fall assessments. 
This registry was used to identify study participants who 
were residents experiencing one or more incident falls 
between July 31, 2009 and July 31, 2010 from one facil-
ity. Incident cases of falls during the study period were 
included if the resident was 65  years of age or older. A 
fall was defined as any unexpected event in which the 
resident comes to rest on the ground, floor, or lower level 
[25].
A standardized case report form was developed for 
chart abstraction purposes. A research assistant col-
lected data from three sources: (1) the electronic medical 
record, (2) medication administration records, and (3) the 
falls registry case report form. The following information 
was collected for each participant: age, vital signs, gen-
der, living status (i.e., long term care or retirement home 
setting), list of medical conditions, list of current medica-
tions (scheduled and as needed), results of most recent 
laboratory test results, resident’s emotional state before 
the fall if observed, from fall report, perceived cause 
of the fall as per nursing note on fall report, any injury 
resulting from the fall, post-fall status, and, additional 
follow up required as a result of the fall. Any changes in 
medical status (e.g., recent infections or exacerbations of 
underlying diseases) or in medications that occurred in 
the 1-month period preceding the fall were also noted. 
Lastly, each resident’s chart was reviewed in detail dur-
ing the immediate 6  month post-fall period to identify 
any aspects of care planning that included addressing 
medications as potential targets for intervention and/or 
referral to the consultant pharmacist for review to lower 
future fall risk. In addition, the medication dispensing 
records for these residents were reviewed during this 
6-month period to ascertain any medications changes 
that might have occurred, but not otherwise documented 
in the progress notes. Fall risk increasing drugs were 
defined as medications that are known to be associated 
with an increased risk for falls such as antihypertensives, 
narcotic analgesics, and various psychotropic medica-
tions [8, 11–13]. The presence of any medication known 
to increase fall risk was noted from each resident’s medi-
cation dispensation data and cross-referenced with their 
medication administration record, and these data were 
captured in the case report form.
Data were entered into a Microsoft Access database 
designed for this project. Given the descriptive nature of 
this study, analyses were largely limited to descriptive sta-
tistics, though limited inferential testing was conducted 
(Chi Squared tests) using Epi-Info-7 software to compare 
FRID among residents by number of falls and place of 
residence. This study was approved by the University of 
Waterloo’s Office for Research Ethics, and individual con-
sent from subjects was not required for this study.
Results
We identified 105 residents who sustained one or more 
falls during the study period. These individuals had 
an average age of 89 (range 61–103) years, 83  % were 
female, with an average number of seven diagnoses and 
nine regularly scheduled medications (Table  1). The 
proportion of residents who fell more than once during 
the one-year study period was 46, and 27  % had a his-
tory of multiple falls in the 6 months preceding the first 
fall in the study period. There were more residents in 
the retirement home section (n =  64) versus long-term 
care (n  =  41). Compared to retirement home dwelling 
residents, those living in long term care had a higher pro-
portion of: residents with a history of one or more prior 
falls (61 vs 36 %), more than one fall during study period 
(60 vs 37 %), multiple comorbidities (8 vs 5), conditions 
associated with increased fall risk such as dementia (63 vs 
34 %), osteoarthritis (44 vs 23 %), depression (42 vs 19 %), 
and visual impairment (63 vs 6  %). Residents in retire-
ment home received an average of 9 regularly scheduled 
medications compared to 8 for LTC residents.
The number of residents experiencing one or more falls 
is summarised in Fig.  1. During the study period, 46  % 
of residents sustained more than one falls, with an over-
all average of 2.2 falls/resident and 3.7 falls/resident for 
those falling 2 or more times. The characteristics of the 
falls are summarised in Table 2. Overall, 42 % of residents 
sustained some type of injury, 24 % aches and pains, and 
2 % sustained a fracture. The proportion of residents sus-
taining injuries was higher for RH (47 %) versus LTC set-
ting (34 %).
Most (65 %) falls occurred in bedrooms or bathrooms 
while 21  % occurred in common areas such as the din-
ing room, hallways, or lounges. The most common activi-
ties prior to falling included walking (40 %), transferring 
(12 %), and turning or standing (12 %). There were some 
differences between RH and LTC residents as there were 
more of the former standing (10 vs 6 %) or transferring 
(16 vs 6 %) at the time of the fall. The emotional/cognitive 
state of the resident was noted in 74 cases and was most 
commonly documented as calm or alert (55 %), confused 
or sleepy (19 %), or agitated or anxious (9 %).
Use of fall risk increasing drugs was common in this 
sample. Statistically significant differences were noted for 
use of antidepressant (82 vs 57 %, p < 0.05) and antipsy-
chotic drugs (39 vs 20 %, p < 0.05) for residents with one 
fall versus those who sustained >1 fall (Table  3), while 
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statistically non-significant differences in the proportion 
of residents receiving diuretics (43 vs 29 %) and narcot-
ics (21 vs 27  %) were also observed. When comparing 
RH residents to those living in LTC (Table 4), those living 
in RH used significantly less antipsychotics (15 vs 46 %, 
p  <  0.05) while statistically non-significant differences 
were noted for SSRIs (34 vs 42 %) and trazodone (11 vs 
20  %). Conversely, residents in LTC used significantly 
less narcotic medications (10 vs 33 %, p < 0.05) and less 
antihypertensive medications (p > 0.05) (Table 4). Lastly, 
11  % of residents were receiving anticonvulsants, while 
use of tricyclic antidepressant and anticholinergic drugs 
was low (5 % each).
Of note, vitamin D and calcium were used by 43 and 
34  % of residents, respectively, while bisphosphonates 
were used by 66 % of residents with osteoporosis. A thor-
ough review of resident’s charts did not reveal any evi-
dence that medication related causes were investigated 
regardless of how many falls the resident sustained. Fur-
thermore, additional review of medication administration 
Table 1 Demographic characteristics of study sample
Numbers above may not add up to final sample due to missing data
CPS score 0–2 = intact cognition to mild cognitive impairment; CPS 3–4 = moderate to moderately severe cognitive impairment; CPS 5–6 = severe to very severe 
cognitive impairment; CPS scores available for 39 residents; CPS scale not routinely done in RH setting
Characteristic N (%) Long term care (n = 41) Retirement home (n = 64)
Gender
 Male 18 (17) 5 (12) 13 (20)
 Female 87 (83) 36 (88) 51 (80)
Mean (SD) age (range) 89 ± 7 (61–103) 89 ± 8 (61–98) 89 ± 6 (67–103)
Use of cane or walker 71 (68) 24 (59) 47 (73)
Use of wheelchair 33 (31) 25 (6) 8 (13)
Visual impairment 30 (29) 26 (63) 4 (6)
Hearing impairment 21 (20) 20 (49) 1 (2)
Medications per resident (mean, SD, range) 9 (4), 1–22 8 (4), 1–18 9 (4), 1–22
Diagnosis per resident (mean, SD, range) 7 (3) (1–15) 8 (3) 3–15 5 (2), 1–9
Number who experienced 1 fall during study period 56 (54) 16 (40) 40 (64)
Number who experienced >1 fall during study period 47 (46) 24 (60) 23 (37)
History of falling in the last 6 months
 Has fallen 1–2 times 20 (19) 10 (24) 10 (16)
 Multiple history of falling 28 (27) 15 (37) 13 (20)
 No history 57 (54) 16 (41) 41 (65)
Diagnoses
 Hypertension 65 (62) 39 (95) 26 (40)
 Osteoarthritis 33 (31) 18 (44) 15 (23)
 Osteoporosis 20 (19) 10 (24) 10 (16)
 Dementia 48 (4 6) 26 (63) 22 (34)
 Depression 29 (28) 17 (42) 12 (19)
 Stroke/TIA 28 (27) 15 (37) 13 (20)
 Anemia 17 (16) 14 (34) 3 (5)
 Cataracts 15 (14) 10 (24) 5 (8)
 Anxiety 12 (11) 10 (24) 2 (3)
 DM 12 (11) 6 (15) 6 (9)
 Hypothyroidism 12 (11) 5 (12) 7 (11)
 Atrial fibrillation 10 (10) 4 (10) 6 (9)
 GERD 10 (10) 7 (17) 3 (5)
 IHD 6 (6) 3 (7) 3 (5)
CPS score
 0–2 11 (28) 10 (26) 1 (100)
 3–4 24 (62) 24 (63) 0 (0)
 5–6 4 (10) 4 (11) 0 (0)
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records did not reveal any medication regimen changes 
in the 6-month period after each fall that was related to 
medications that might have played a role in falls. No 
pharmacy consultant notes could be located for any of 
these residents during the same time period.
Discussion
We found that LTC and RH residents with a recent fall 
were commonly receiving multiple FRIDs and multi-
ple medications. Patterns of FRID use differed some-
what between those who sustained 1 versus >1 fall, and 
between residents living in LTC versus RH settings. 
Overall, residents who sustained >1 fall had a high bur-
den of FRIDs relative to residents with only one fall as 
demonstrated by higher proportions of benzodiazepine, 
diuretic, renin-angiotensin-aldosterone inhibitors, anti-
depressant, and antipsychotic drugs. Our sample had a 
predominance of women, a significant burden of fall risk 
factors such as polypharmacy, previous falls, dementia, 
older age, sensory impairments, use of assistive ambula-
tory devices, and a high prevalence of post fall injuries.
Benzodiazepine, antidepressant, and antipsychotic 
medication use among LTC residents was common, con-
sistent with prior findings in LTC settings [20, 21, 26]. 
Conversely, antihypertensive drugs, narcotics, vitamin D 
and/or calcium supplements were less commonly used in 
LTC residents. The latter two observations are consist-
ent with studies documenting low rates of analgesic and 
anti-osteoporotic drug use in this setting [27, 28]. Vita-
min D has been associated with a reduced risk for falls, 
is well tolerated and inexpensive, and thus represents an 
opportunity to reduce fall risk in this vulnerable popula-
tion [2, 29]. Similarly, use of supplemental calcium could 
also be improved given the high prevalence of osteoporo-
sis in this setting [30]. The lower rates of antihypertensive 
medication and narcotic use in LTC residents compared 
with RH residents may represent a conscious effort on 
the part of prescribers to avoid using these medications 
in an ostensibly frail population. Alternatively, lower 
rates of narcotic use in LTC residents may be due to inad-
equate recognition of pain, especially among residents 
with cognitive impairment [31].
With regards to the role that consultant pharmacists 
could have played in falls risk reduction strategies, our 
findings were revealing. Review of the resident’s charts 
revealed no medication regimen reviews from consult-
ant pharmacists that addressed fall risk reduction, nor 
were such reviews requested by staff post-fall to assess 
the potential contribution of medications to falls. Dur-
ing discussions with the principal investigator, consultant 
pharmacists noted that every quarter, they received a list 
of residents who had fallen, but they felt that this time lag 
made subsequent medication regimen reviews futile. The 
pharmacists also noted that their consult notes are often 
misplaced (it is unclear why this is so) and thus seldom 
reach the attending physician. It was also apparent that 
medication regimen reviews were not being conducted in 
a systematic manner that could otherwise aid in identify-
ing potentially modifiable medication related fall risk fac-
tors [9, 15, 32]. Lastly, pharmacists noted that falls care 
plans for residents who had fallen did not include phar-








1 fall 2 falls 3 falls 4 falls 5 or more
falls
% of residents who
experienced falls
Fig. 1 Frequency of falls among 105 residents
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conferences. As such, pharmacists appeared to be work-
ing in isolation rather than as part of the interdisciplinary 
team.
These findings are concerning, as in Ontario the Min-
istry of Health requires and reimburses pharmacists to 
conduct on-going medication reviews for nursing home 
residents and to participate in interdisciplinary meet-
ings to evaluate medication regimens. The quarterly 
medication regimen review would appear to present an 
ideal opportunity to address medication related issues 
of relevance to falls, as medications represent one of 
the most modifiable risk factors for falls. Indeed, prior 
studies in community settings have demonstrated that 
reducing FRIDs can result in a 39–66 % reduction in falls 
which is of relevance to RH residents in the present study 
[16, 17, 33–35].
Indeed, a fall in either the NH or RH setting should trig-
ger a thorough and systematic medication regimen review 
as part of a comprehensive care plan, with particular 
attention to blood pressure lowering drugs, psychotropic 
drugs, and optimization of vitamin D and calcium sta-
tus, though it is clear that further research is necessary to 
clarify the role of medication based programs as a tool for 
reducing fall risk, and ultimately, falls [9, 15, 29].
On a positive note, consultant pharmacists suggested 
their awareness of potentially modifiable medication 
Table 2 Characteristics of falls (N = 105 residents)
Numbers above may not add up to final sample due to missing data
Characteristic N (%) Long  






 Aches/pain 24 (24) 6 (16) 18 (29)
 Bruising/bumps 22 (22) 8 (21) 14 (23)
 Skin tear/cut 20 (20) 6 (16) 14 (23)
 Fracture/break 2 (2) 0 (0) 2 (3)
 No injury 44 (44) 22 (58) 22 (36)
Location
 Activity room 1 (1) 0 (0) 1 (2)
 Balcony 1 (1) 1 (3) 0 (0)
 Bathroom 15 (16) 3 (8) 12 (20)
 Bedroom 53 (55) 20 (54) 33 (55)
 Dining room 4 (4) 2 (5) 2 (3)
 Hallways 11 (11) 4 (11) 7 (12)
 Lounge 7 (7) 6 (16) 1 (2)
 Other 5 (5) 1 (3) 4 (7)
Prior activity
 Lying down 3 (3) 2 (6) 1 (2)
 Eating 1 (1) 1 (3) 0 (0)
 Reaching 7 (8) 2 (6) 5 (9)
 Sitting 6 (7) 2 (6) 4 (7)
 Sleeping 1 (1) 1 (3) 0 (0)
 Standing 8 (9) 2 (6) 6 (10)
 Tidying room 1 (1) 1 (3) 0 (0)
 Transfer 11 (12) 2 (6) 9 (16)
 Turning 5 (5) 1 (3) 4 (7)
 Walking 37 (40) 15 (46) 22 (38)
 Unknown 11 (12) 4 (12) 7 (12)
Emotional state
 Agitated 2 (3) 1 (4) 1 (2)
 Alert 13 (18) 9 (32) 4 (9)
 Anxious 5 (7) 3 (11) 2 (4)
 Calm 28 (38) 17 (61) 11 (24)
 Confused 9 (12) 6 (21) 3 (7)
 Depressed 1 (1) 0 (0) 1 (2)
 Sleepy 5 (7) 1 (4) 4 (9)
 Unknown 31 (42) 4 (14) 27 (59)
 Unwitnessed 1 (1) 0 (0.0) 1 (2)
Table 3 Frequency of  falls risk increasing medication use 
for single versus multiple falls
* p < 0.05 for comparison of residents with 1 fall versus >1 fall. Comparisons are 

















16 (29) 14 (30)
 Calcium‑channel antago‑
nists
15 (27) 6 (13)




20 (36) 19 (40)
Antidepressants*
 Serotonin reuptake 
inhibitors
16 (29) 23 (47)
 Trazodone 6 (11) 9 (19)
 Tricyclic and other nor‑
epinephrine‑reuptake 
inhibitors
3 (5) 2 (4)
 Serotonin and norep‑
inephrine‑reuptake 
Inhibitors
2 (4) 2 (4)
 Mirtazapine 5 (9) 4 (9)
Antipsychotics*
 Typical 0 (0) 2 (4)
 Atypical 11 (20) 17 (35)
Narcotics 15 (27) 10 (21)
Digoxin 2 (4) 2 (4)
Anticholinergics 4 (7) 5 (10)
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related risk factors could be improved if a simple algo-
rithm existed that could assist them during their medi-
cation regimen reviews, and that they would use such a 
tool in their practice. This suggestion proved fruitful, and 
given the absence of a brief and practical tool, our group 
developed and pilot tested a brief algorithm to reduce fall 
risk attributable to FRIDs [15]. Use of this this instrument 
was found to be feasible in practice, and led to an abso-
lute increase of 20 % in pharmacist’s suggestions related 
to fall risk reduction. It was also pointed out that use of 
supplemental calcium decreased dramatically in LTC 
facilities following publication of studies demonstrat-
ing an association between calcium supplement use and 
increase risk of vascular events, despite major limitations 
of these data [36]. Such information has proved valuable, 
as it has identified areas for future education and inter-
vention efforts aimed at lowering fall risk and optimising 
the use of consultant pharmacy services.
Limitations
There are inherent limitations in retrospective studies. 
The reasons behind the lack of thorough medication regi-
men reviews post fall, especially in residents with more 
than one fall could not be ascertained from the medical 
records. Sample size may be considered as a limitation in 
terms of generalizability and statistical ability to detect 
differences between groups, yet our study provides more 
granular data compared with database studies, in par-
ticular with regards to proximal outcomes of falls, prior 
activity, and falls in a RH setting, where data thus far are 
scant. In addition, these data might be ostensibly general-
izable to the other 12 facilities (total census 3309) as they 
are all operated by the same organisation with identical 
standard operating procedures. The exact role that FRIDs 
played in these resident’s falls could not be ascertained 
from this study. It should be stressed that this is no differ-
ent from clinical practice. In practice, clinicians are left to 
sort through potential contributors to falls after a person 
has fallen, in much the same manner as in the present 
study. We relied on a single source of falls data to identify 
residents, but have no data describing the accuracy of the 
falls incident reporting system used in this facility, thus 
it is possible that falls are underreported. Lastly, we were 
unable to ascertain dietary intake of calcium and vitamin 
D.
This study nonetheless offers a contemporary and 
detailed analysis of use of FRIDs in a vulnerable sample 
of LTC and RH residents who have fallen. These data 
represent an important step in understanding where to 
focus future quality improvement efforts aimed at reduc-
ing modifiable falls risk factors, with the ultimate goal 
of reducing falls across the 12 facilities of the broader 
organization, which provides services to approximately 
3080 older residents in south-western Ontario, Canada.
Implications for practice and research
There are many implications for practice, and perhaps 
the most salient is the necessity for consultant pharma-
cists to adopt a systematic approach to resident care, 
which would be helpful in identifying medication-related 
fall risk factors [10, 15, 32]. Consistent with known asso-
ciations between various medications and falls, psycho-
tropic drugs, antihypertensives, and the use of multiple 
medications should remain in the forefront of fall risk 
reducing strategies for LTC residents who experience 
falls. Similarly, for residents with multiple falls, psycho-
tropic drugs and blood pressure lowering drugs are like-
wise good targets for fall risk reduction [16, 17, 37–39]. 
Lastly, optimising calcium and vitamin D intake (through 
any means possible) represent a parsimonious opportu-
nity to reduce fall risk and improve bone health. In addi-
tion, while it may be useful for falls incident reports to 
Table 4 Frequency of  falls risk increasing medication use 
according place of residence
* p < 0.05 for comparison of residents residing in long term care versus 




Long term care  
(n = 41 residents) 
N (%)









8 (20) 22 (34)
 Calcium‑channel 
antagonists
7 (17) 14 (22)




16 (39) 23 (36)
Antidepressants
 Serotonin reuptake 
inhibitors
17 (42) 22 (34)
 Trazodone 8 (20) 7 (11)
Tricyclic and other nor‑
epinephrine‑reuptake 
Inhibitors
1 (2) 4 (6)
 Serotonin and norep‑
inephrine‑reuptake 
Inhibitors
2 (5) 2 (3)
 Mirtazapine 3 (7) 6 (9)
Antipsychotics*
 Typical 0 (0) 2 (3)
 Atypical 19 (46) 8 (13)
Narcotics* 4 (10) 21 (33)
Digoxin 1 (2) 3 (5)
Anticholinergic drugs 6 (14) 3 (5)
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be shared with pharmacists in a more timely manner 
(e.g., within one week of the fall), potentially modifiable 
risk factors can still be identified and addressed even if 
medication regimen reviews are conducted at a later 
date, especially in light of our findings that no reviews 
appeared to be conducted even among residents who fell 
multiple times.
From the research perspective, additional work will be 
conducted to further develop and test our falls algorithm 
instrument on a larger scale, establish its utility in prac-
tice, and study the ability of this instrument to help phar-
macists reduce the incidence of falls. In addition, while it 
is difficult to assess the potential contribution of medica-
tions to falls in individual patients in practice, there is a 
need to develop methods that may assist pharmacists in 
identifying the most likely drug(s) that may be contrib-
uting to falls and which medications might be superflu-
ous, which in turn would aid in the overall care plan for 
these residents. Lastly, despite the success of multifac-
torial interventions in reducing falls in LTC such inter-
ventions are not routinely or readily incorporated into 
practice [8–10, 40]. It is possible that these programmes 
are too time or labour intensive, or that the closed sys-
tem LTC infrastructure does not readily permit uptake 
of these models. Indeed, Haralambous et al. [24] recently 
suggested that an action research approach is useful in 
the context of engaging staff in falls prevention strate-
gies that are sustainable and contextually appropriate. In 
this regard, long-term care facilities represent ideal set-
tings to continue to investigate novel methods to lower 
fall risk and falls. Given the challenges associated with 
complex interventions that may not be readily sustain-
able, it may be possible to improve fall risk reduction by 
using multidisciplinary health care team members who 
are already providing care to these residents, namely the 
consultant pharmacist. Lastly, results from this research 
project are being utilized as part of a multifaceted clinical 
research program to lower fall risk and ultimately lower 
fall rates by optimising medication use in this vulnerable 
population. This program also involves multiple health 
care professionals and addresses systems issues aimed at 
developing practice based changes that are sustainable 
over the long term.
Conclusion
In conclusion, the present study documented common 
use of FRIDs by LTC and RH residents with multiple 
falls. These potentially modifiable falls risk factors are not 
being adequately addressed in contemporary practice, 
demonstrating that there is much room for improvement 
with regards to the safe and appropriate use of medica-
tions in LTC and RH residents and lowering resident fall 
risk.
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